DSI Research Northridge LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Crohn's disease1 trial
• Obesity1 trial
• Ulcerative colitis1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Kowa Research Institute, Inc.1 trial
• Takeda1 trial

Running trials

• Recruiting

  A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  NCT06581328· Phase 4· Takeda· Source

  Contact: Rajeev Kurapati (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

  NCT06309992· Phase 3· Boehringer Ingelheim· Source

• Completed

  Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

  NCT05327127· Phase 2· Kowa Research Institute, Inc.· Source